Serous Ovarian Tumor (DBCOND0119505)
Identifiers
- Synonyms
- Ovarian Serous Tumor
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT06180356 Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression treatment 2 recruiting NCT06274541 Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study No drug interventions Not Available Not Available active_not_recruiting NCT03926936 FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study treatment 2 completed NCT02446600 Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 3 active_not_recruiting NCT03456700 Auranofin and Sirolimus in Treating Participants With Ovarian Cancer treatment 2 active_not_recruiting NCT02595892 Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer treatment 2 active_not_recruiting NCT03685695 Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer No drug interventions supportive_care 2 completed NCT02520115 Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer treatment 1 completed NCT02627430 Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer treatment 1 withdrawn